Legato Capital Management LLC Sells 5,808 Shares of Nutex Health Inc. (NASDAQ:NUTX)

Legato Capital Management LLC lessened its position in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 18.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 25,861 shares of the company's stock after selling 5,808 shares during the period. Legato Capital Management LLC owned about 0.47% of Nutex Health worth $1,216,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of NUTX. Bank of America Corp DE lifted its holdings in Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after buying an additional 2,043 shares during the last quarter. Northern Trust Corp acquired a new stake in shares of Nutex Health during the 4th quarter worth approximately $200,000. Millennium Management LLC acquired a new stake in shares of Nutex Health during the 4th quarter worth approximately $213,000. World Investment Advisors acquired a new stake in shares of Nutex Health during the 4th quarter worth approximately $217,000. Finally, OMERS ADMINISTRATION Corp acquired a new stake in shares of Nutex Health during the 4th quarter worth approximately $231,000. Institutional investors own 5.32% of the company's stock.

Nutex Health Stock Down 0.8%

Shares of Nutex Health stock traded down $0.73 during midday trading on Friday, hitting $95.02. The company's stock had a trading volume of 165,930 shares, compared to its average volume of 377,148. The firm has a market capitalization of $527.84 million, a P/E ratio of 7.99 and a beta of -0.04. The stock has a 50-day simple moving average of $128.90 and a 200-day simple moving average of $94.99. The company has a quick ratio of 2.26, a current ratio of 2.27 and a debt-to-equity ratio of 1.02. Nutex Health Inc. has a 1-year low of $6.45 and a 1-year high of $184.27.

Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $2.71. Nutex Health had a return on equity of 42.08% and a net margin of 10.76%. The business had revenue of $211.79 million during the quarter, compared to analyst estimates of $81.09 million.

Wall Street Analyst Weigh In

NUTX has been the topic of several analyst reports. Benchmark raised their target price on Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research report on Thursday, May 15th. Wall Street Zen cut Nutex Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd. Finally, Maxim Group raised their target price on Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research report on Tuesday, May 20th.

Nutex Health Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.